Department of Cardiology, University Hospital, Opole, Poland.
Division of Clinical Electrophysiology, Department of Cardiology, Centre of Postgraduate, Grochowski Hospital, Warsaw, Poland
Kardiol Pol. 2020 Oct 23;78(10):974-981. doi: 10.33963/KP.15407. Epub 2020 Jun 2.
Catheter ablation is an effective treatment for patients with atrial fibrillation (AF). Despite the increasing availability of the procedure, current treatment patterns of invasive AF treatment in Poland are unknown.
The aim of the study was to assess data on the contemporary approaches to AF ablation in Poland, such as: target population, patients' characteristics, ablation techniques, procedural results, and complication rates.
The survey including 36 questions was conducted among 38 representatives of Polish electrophysiology centers performing AF catheter ablation to test the methods and outcomes in their laboratories.
The survey was conducted among 38 out of 69 Polish electrophysiology centers performing AF ablation. There were 88 ablation laboratories in 2018 in Poland. They have performed 16 566 ablations, of which 6680 were AF ablations, according to the Polish National Health Fund data. Therefore, 3745 AF ablations analyzed in this study constituted 22.6% of all ablations and 56% of AF ablations performed in Poland in 2018.Paroxysmal AF was the most common type of AF in all surveyed centers. In 69% of the centers, the preferred method was cryoballoon ablation and in 31%, radiofrequency point‑by‑point circumferential pulmonary vein isolation. The reported complication rate was low (6.4%), with localadverse events being the most frequent. The mean reported incidence of atrial flutter or tachycardia after ablation was low (5%). Repeated procedures were performed mainly with radiofrequency ablation (89%). Procedural techniques and the type of venous access did not vary between the centers.
Paroxysmal AF was the most common indication for percutaneous ablation of that arrhythmia in Polish electrophysiology laboratories. The preferred method was cryoballoon ablation.
导管消融是治疗心房颤动(AF)患者的有效方法。尽管该手术的应用越来越广泛,但目前波兰对侵入性 AF 治疗的治疗模式尚不清楚。
本研究旨在评估波兰当前 AF 消融的治疗方法数据,例如:目标人群、患者特征、消融技术、手术结果和并发症发生率。
这项调查包括 36 个问题,对 38 名在波兰进行 AF 导管消融的电生理中心代表进行了调查,以测试其实验室的方法和结果。
该调查是在 38 个进行 AF 消融的波兰电生理中心中进行的。2018 年,波兰共有 88 个消融实验室,根据波兰国家卫生基金的数据,共进行了 16566 次消融术,其中 6680 次是 AF 消融术。因此,在这项研究中分析的 3745 次 AF 消融术构成了所有消融术的 22.6%和 2018 年波兰进行的 AF 消融术的 56%。阵发性 AF 是所有调查中心最常见的 AF 类型。在 69%的中心,首选方法是冷冻球囊消融,而在 31%的中心,首选方法是射频逐点环形肺静脉隔离。报告的并发症发生率较低(6.4%),最常见的是局部不良事件。报告的消融后房性扑动或心动过速的发生率较低(5%)。主要进行重复手术的方法是射频消融(89%)。各中心之间的手术技术和静脉入路类型没有差异。
阵发性 AF 是波兰电生理实验室进行经皮消融的最常见适应证。首选方法是冷冻球囊消融。